NCT05155995

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers

A Randomized, Open Label, Single Dose, 2-way Crossover Clinical Trial to Evaluate the Pharmacokinetic Characteristics and Safety Between After Administration of a Fixed-dose Combination Drug of HCP2001 and Co-administration of Each Component in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 71 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: All
• Age: 19 Years – 54 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the pharmacokinetic characteristics and safety between HCP2001 and co-administration of each component in fasting and fed conditions respectively in healthy volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	HCP2001	Take it once per period.
DRUG	RLD2007	Take it once per period.
DRUG	RLD2008	Take it once per period.
DRUG	RLD2102	Take it once per period.

Timeline

• Start date: 2021-09-28
• Primary completion: 2022-11-27
• Completion: 2022-11-27
• First posted: 2021-12-14
• Last updated: 2023-09-22

Locations

1 site across 1 country: South Korea